Squarepoint’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162K Sell
82,716
-8,547
-9% -$20.1K ﹤0.01% 4002
2025
Q4
$247K Buy
+91,263
New +$300K ﹤0.01% 3734
2025
Q3
Sell
-92,623
Closed -$461K 4572
2025
Q2
$461K Buy
+92,623
New +$402K ﹤0.01% 3339
2024
Q3
Sell
-41,344
Closed -$322K 4300
2024
Q2
$322K Buy
41,344
+19,407
+88% +$144K ﹤0.01% 3390
2024
Q1
$156K Buy
+21,937
New +$145K ﹤0.01% 3694
2023
Q4
Sell
-96,986
Closed -$546K 4173
2023
Q3
$546K Buy
+96,986
New +$647K ﹤0.01% 2742
2023
Q2
Sell
-63,321
Closed -$396K 3712
2023
Q1
$396K Sell
63,321
-70,253
-53% -$392K ﹤0.01% 2424
2022
Q4
$622K Sell
133,574
-42,672
-24% -$210K ﹤0.01% 2143
2022
Q3
$823K Sell
176,246
-39,588
-18% -$250K ﹤0.01% 1890
2022
Q2
$1.28M Buy
215,834
+177,360
+461% +$1.97M 0.01% 1459
2022
Q1
$744K Buy
38,474
+24,872
+183% +$570K ﹤0.01% 1767
2021
Q4
$445K Buy
+13,602
New +$547K ﹤0.01% 2211
2021
Q3
Sell
-33,235
Closed -$1.21M 3087
2021
Q2
$1.2M Buy
33,235
+12,541
+61% +$463K ﹤0.01% 1508
2021
Q1
$807K Sell
20,694
-79,806
-79% -$3.59M ﹤0.01% 1677
2020
Q4
$4.05M Sell
100,500
-100,500
-50% -$4.62M 0.03% 578
2020
Q3
$11.2M Buy
+201,000
New +$10.6M 0.15% 161

Other funds holding GDRX

Squarepoint's GDRX Position: Q1 2026 in Review

Squarepoint reduced its GoodRx Holdings (GDRX) stake by 9.4% in Q1 2026, selling an estimated $20.1K and leaving 82,716 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #4002.

Squarepoint first reported a position in GDRX in Q3 2020 and has held it in 16 quarters since. The position peaked at $11.2M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Squarepoint held 82,716 shares of GoodRx Holdings worth $162K as of Q1 2026.
  • Squarepoint sold 8,547 GoodRx Holdings shares in Q1 2026, an estimated $20.1K.
  • GoodRx Holdings made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4002 holding.
  • Squarepoint first reported a position in GoodRx Holdings in Q3 2020 and has held it in 16 quarters since.
  • Squarepoint's GoodRx Holdings position peaked at $11.2M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.